تفاعل #1726677

ord-4f77df9535d24fed899d36b256c7a891

معادلة التفاعل

[H][H]
hydrogen
c1cnc2c(c1)ccc1cccnc12
1,10-phenanthroline
O.c1ccncc1
pyridine water
O=C(O)C(F)(F)F
trifluoroacetic acid
FC(F)(F)c1ccccc1S
2-trifluoromethylthiophenol
[H-].[Na+]
sodium hydride
[H][H]
hydrogen
FC(F)(F)c1ccccc1Sc1ccccc1N1CCNCC1
1-[2-(2-Trifluoromethylphenylsulfanyl)phenyl]piperazine

ظروف التفاعل

درجة الحرارة
55°CELSIUS
الظروف التفصيلية
See reaction.notes.procedure_details.

المعالجة

  1. 1
    درجة الحرارةAfter cooling to room temperature
  2. 2
    ترشيحthe resin was filtered off
  3. 3
    غسيلwashed with tetrahydrofuran (2×50 mL), tetrahydrofuran/water (1:1) (2×50 mL), N,N-dimethylformamide (2×50 mL), water (2×50 mL), methanol (3×50 mL), tetrahydrofuran (3×50 mL)
  4. 4
    غسيلFinally, the resin was washed with dichloromethane (3×50 mL)
  5. 5
    أخرىdried in vacuo (25° C., 12 h)
  6. 6
    أخرىto yield a dark orange resin
  7. 7
    أخرىwas placed in light-transparent reactor tube
  8. 8
    workup.STIRRINGThe suspension was agitated by rotation under irradiation with visible light for 12 h
  9. 9
    ترشيحThe resin was filtered
  10. 10
    غسيلwashed with methanol (2×25 mL), water (2×25 mL) and tetrahydrofuran (3×25 mL) until the washing solutions
  11. 11
    أخرىthe irradiation procedure
  12. 12
    غسيلthe resin was washed with dichlormethane (3×25 mL)
  13. 13
    أخرىdried in vacuo (25° C., 12 h)
  14. 14
    أخرىto obtain a light brown resin
  15. 15
    workup.STIRRINGstirred at room temperature for 2 h
  16. 16
    ترشيحThe resin was filtered off
  17. 17
    غسيلwashed with methanol (1×0.5 mL) and dichloromethane (1×0.5 mL)
  18. 18
    أخرىThe filtrates were collected
  19. 19
    أخرىthe volatile solvents evaporated in vacuo
  20. 20
    أخرىThe crude product was purified by preparative LC-MS and subsequently by ion-exchange chromatography
  21. 21
    أخرىRT=2.39

الإجراء التجريبي

To a solution of 2-trifluoromethylthiophenol (1.75 g, 9.8 mmol) in a 1:1 mixture of tetrahydrofuran/dimethylformamide (30 mL), sodium hydride (7.4 mmol, 60% in mineral oil) was carefully added at room temperature (Caution: Generation of hydrogen). The mixture was stirred for an additional 30 min after the generation of hydrogen had ceased. Subsequently, 4-({4-[η6-(2-chloro-phenyl)-η5-cyclopentadienyliron(II)]piperazin-1-yl}carbonyloxymethyl)phenoxymethyl polystyrene hexafluorophosphate (3.5 g, 2.45 mmol) was added and the mixture was stirred at 55° C. for 12 h. After cooling to room temperature, the resin was filtered off and washed with tetrahydrofuran (2×50 mL), tetrahydrofuran/water (1:1) (2×50 mL), N,N-dimethylformamide (2×50 mL), water (2×50 mL), methanol (3×50 mL), tetrahydrofuran (3×50 mL), and subsequently with methanol and tetrahydrofuran (each 50 mL, 5 cycles). Finally, the resin was washed with dichloromethane (3×50 mL) and dried in vacuo (25° C., 12 h) to yield a dark orange resin. The thus obtained resin and a 0.5 M solution of 1,10-phenanthroline in 3:1 mixture of pyridine/water (20 mL) was placed in light-transparent reactor tube. The suspension was agitated by rotation under irradiation with visible light for 12 h. The resin was filtered and washed with methanol (2×25 mL), water (2×25 mL) and tetrahydrofuran (3×25 mL) until the washing solutions were colourless (approx. 5 cycles) and the irradiation procedure was repeated until decomplexation was complete (approx. 5 cycles). After the decomplexation was completed, the resin was washed with dichlormethane (3×25 mL) and dried in vacuo (25° C., 12 h) to obtain a light brown resin. 100 mg (77 μmol) of the thus obtained resin were suspended in a 1:1 mixture of trifluoroacetic acid and dichlormethane (2 mL) and stirred at room temperature for 2 h. The resin was filtered off and washed with methanol (1×0.5 mL) and dichloromethane (1×0.5 mL). The filtrates were collected and the volatile solvents evaporated in vacuo. The crude product was purified by preparative LC-MS and subsequently by ion-exchange chromatography. LC/MS (m/z) 339 (MH+); RT=2.39; purity (UV, ELSD): 92%, 100%; overall yield: 1 mg (4%).

المصدر

DOI: 10.6084/m9.figshare.5104873.v1براءة الاختراع: US08110567B2uspto-grants-2012_02